The US FDA's cancer drug approval process is broken and needs audit
Sensible Medicine
APRIL 25, 2024
Selenexor is a toxic poison that does not increase survival. In the latest project from our team , led by medical student Josh Elbaz, we examine how many FDA approvals from 2006 to 2023 improve survival. COVID19 vaccines have never shown benefit with respect to clinical outcomes among people who already had COVID.
Let's personalize your content